Drug Page

In a review editorial for the journal Psychotherapy and Psychosomatics, neurobiology researcher Steven Dubovsky from the University at Buffalo argues against the adoption of...

Writing for Forbes, Matthew Herper documents the FDA’s increasing drug approval rates. “In 2008, BioMedTracker says the FDA approved 20 new molecular entities (NMEs) and rejected 20, for an approval rate of 50%.” So far this year, he writes, “the FDA approval rate is more like 96%.”

Last year the British Medical Association (BMA) released a report on dependence and withdrawal from prescription drugs including benzodiazepines, z-drugs, opioids, and antidepressants. Now,...

“Adolescents whose mothers took certain antidepressants while pregnant with them are more than four times as likely to become depressed by age 15, compared with...

For STAT, Meghana Kashavan reports on a new, candy-flavored, chewable, fruity, amphetamine drug on the market for children diagnosed with ADHD. “It’s a move...

Gepirone, a new depression drug by Fabre-Kramer Pharmaceuticals, did not meet the FDAs efficacy standards. The new drug application for gepirone has now received...

The official voice of the American Psychiatric Association covers the short and long term side-effects of antipsychotics and promotes the use of therapeutic alternatives...

The UK Independent reports that Ireland is moving toward a policy of decriminalizing small amount of drugs like heroin, cocaine, and cannabis in what amounts to a “radical cultural shift.” While it would remain a crime to profit from the sale of these substances, users will have specially designated areas for safe use. The chief of Ireland’s National Drugs Strategy told the paper: “I am firmly of the view that there needs to be a cultural shift in how we regard substance misuse if we are to break this cycle and make a serious attempt to tackle drug and alcohol addiction.”

Miriam Stoppard writes an opinion piece on the lack of good research on Ritalin, a drug often used for ADHD, and discusses the latest Cochrane review which found a high percentage of side-effects in children. Despite the lack of quality evidence, “NHS figures show that nearly one million ADHD prescriptions were handed out last year in England – a number that has more than doubled in 10 years.”

In a new article for Scientific American, Diana Kwon reports on how the true risks for suicide and aggression in children and teens taking...

This Sunday, June 12 at 7pm (EDT) on NBCs Dateline will cover MIA author Steve Francesco's book, Overmedicated and Undertreated: How I Lost My...

The BBC reports that the number of people in Scotland taking antidepressants has increased by 5% in the past year with most of the patients being women and those in the poorest parts of the country. “We are now looking at the flabbergasting statistic of more than one in seven people in Scotland being prescribed antidepressants this year,” Conservative health spokesman Jackson Carlaw said. “We urgently have to look at better alternatives than simply parking people on medication in the hope things don't get any worse, with no aspiration for complete recovery."

Ed Silverman at STAT reports that Congress has linked increased research funding to “fast-track” approval procedures. “By linking the extra funds to speedier approvals,...

The New York Times reports that a growing number of infants and toddlers are being prescribed dangerous psychiatric drugs. “Almost 20,000 prescriptions for risperidone (commonly known as Risperdal), quetiapine (Seroquel) and other antipsychotic medications were written in 2014 for children 2 and younger, a 50 percent jump from 13,000 just one year before.”

The All-Party Parliamentary Group for Prescribed Drug Dependence is meeting today, May 11th, to discuss evidence of the link between the rise in disability...

A phase 1 study for a stem cell derived agent that promotes the growth of new nerve cells in the brain demonstrated efficacy in a very small sample of patients diagnosed with major depressive disorder (MDD). The phase 1B study was published online December 8 in Molecular Psychiatry.

Drug Watch releases an in-depth investigation into the marketing practices of pharmaceutical companies in the United States. “Companies spend billions advertising to doctors to...

New data reveals that the majority of care homes in British Columbia, Canada are giving out prescriptions for antidepressants and antipsychotics without a diagnosis....

In a bellwether case, plaintiffs allege that Pfizer did not adequately warn patients that Zoloft (sertraline) would cause birth defects. The case is scheduled in Federal Court in March, and the verdict will have significant implications for future suits.

Medscape Psychiatry reports that the “man-made epidemic” of opioid abuse in the United States is the result of over-prescription and poor research.